Today’s news
Innovative Cancer Immunotherapy Targets Tumors Without Weakening Immune System
Researchers explore new approaches to overcome cancer's ability to evade the immune system.
Danaher To Acquire Medical Tech Firm Masimo For Nearly $10 Billion
The deal will add patient-monitoring devices and related software to Danaher's portfolio of biotechnology, life sciences and diagnostics products.
PharmaResearch Receives FDA Clearance for Phase 1 Trial of Nano Anticancer Drug
The new drug candidate, PRD-101, utilizes the company's proprietary DNA optimizing technology.
